BioSyent (RX) News Today → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free RX Stock Alerts C$8.40 0.00 (0.00%) (As of 04/23/2024 05:13 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesInsider TradesStock AnalysisChartEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBioSyent Inc.: BioSyent Announces Extension of RepaGyn and Proktis-M Agreementfinanznachrichten.de - April 16 at 10:57 AMBioSyent Inc.'s (CVE:RX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?finance.yahoo.com - April 4 at 10:20 AMFeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Yearmarkets.businessinsider.com - April 3 at 2:49 PMBioSyent Inc.: BioSyent Releases Financial Results for Fourth Quarter and Full Year 2023finanznachrichten.de - March 21 at 5:39 AMEarnings call: BioSyent Inc. reports robust growth in Q4 and FY 2023uk.investing.com - March 16 at 7:33 PMBioSyent Named to 2024 TSX Venture 50markets.businessinsider.com - February 21 at 10:25 AMRX:CA BioSyent Inc.seekingalpha.com - February 17 at 10:24 AMBioSyent (CVE:RX) Stock Price Crosses Above Fifty Day Moving Average of $8.73marketbeat.com - February 16 at 5:08 AMBioSyent (CVE:RX) Share Price Crosses Below 50 Day Moving Average of $8.70marketbeat.com - February 8 at 6:30 AMBioSyent Declares First Quarter 2024 Dividendmarkets.businessinsider.com - February 6 at 11:12 PMIs It Smart To Buy BioSyent Inc. (CVE:RX) Before It Goes Ex-Dividend?finance.yahoo.com - November 24 at 8:58 AMBioSyent Announces the Availability of Gelclair® in Canadafinance.yahoo.com - November 20 at 1:00 PMBloom Burton Believes Biosyent (RX) Won’t Stop Heremarkets.businessinsider.com - November 20 at 7:59 AMBioSyent Releases Q3 and YTD 2023 Financial Resultsfinance.yahoo.com - November 16 at 8:20 AMBioSyent Declares Fourth Quarter 2023 Dividendmarkets.businessinsider.com - November 15 at 7:53 PMInvestors in BioSyent (CVE:RX) have seen returns of 21% over the past yeares-us.finanzas.yahoo.com - October 23 at 6:40 PMClosing Bell: Biosyent Inc flat on Tuesday (RX)theglobeandmail.com - October 18 at 2:58 PMBioSyent Launches "menopauseinformation.ca" on World Menopause Daytheglobeandmail.com - October 18 at 2:58 PMClosing Bell: Biosyent Inc flat on Wednesday (RX)theglobeandmail.com - August 31 at 3:18 AMWhy You Might Be Interested In BioSyent Inc. (CVE:RX) For Its Upcoming Dividendfinance.yahoo.com - August 26 at 5:29 PMEstimating The Intrinsic Value Of BioSyent Inc. (CVE:RX)finance.yahoo.com - August 24 at 8:07 AMBioSyent Inc.: BioSyent Releases Q2 and H1 2023 Financial Resultsfinanznachrichten.de - August 23 at 8:59 AMBioSyent Declares Third Quarter 2023 Dividendmarkets.businessinsider.com - August 22 at 5:24 PMBioSyent Launches Inofolic® for Women with Polycystic Ovary Syndrome (PCOS)finance.yahoo.com - August 8 at 10:02 AMClosing Bell: Biosyent Inc down on Monday (RX)theglobeandmail.com - July 18 at 1:57 AMBioSyent Pharma to Introduce Gelclair® at AHNS 11th International Conference on Head and Neck Cancerfinance.yahoo.com - July 6 at 7:24 PMBioSyent Announces Long-term Extension of Cathejell® Agreementfinance.yahoo.com - June 20 at 10:54 AMBioSyent Announces Approval of New Productfinance.yahoo.com - May 31 at 7:20 PMBioSyent Inc.: BioSyent Releases Financial Results for Q1 2023finanznachrichten.de - May 26 at 11:10 AMBioSyent Releases Financial Results for Q1 2023finance.yahoo.com - May 26 at 11:10 AMBioSyent Declares Second Quarter 2023 Dividenduk.finance.yahoo.com - May 25 at 8:31 PMInvesting in BioSyent (CVE:RX) three years ago would have delivered you a 88% gainuk.news.yahoo.com - May 14 at 11:58 PMClosing Bell: Biosyent Inc up on Tuesday (RX)theglobeandmail.com - May 3 at 2:04 PMClosing Bell: Biosyent Inc down on Friday (RX)theglobeandmail.com - April 29 at 9:24 AMClosing Bell: Biosyent Inc down on Thursday (RX)theglobeandmail.com - April 28 at 2:49 PMClosing Bell: Biosyent Inc down on Tuesday (RX)theglobeandmail.com - April 19 at 9:37 AMClosing Bell: Biosyent Inc up on Monday (RX)theglobeandmail.com - April 18 at 8:29 AMClosing Bell: Biosyent Inc up on Friday (RX)theglobeandmail.com - April 15 at 1:04 PMClosing Bell: Biosyent Inc up on Wednesday (RX)theglobeandmail.com - April 13 at 1:38 AMClosing Bell: Biosyent Inc down on Wednesday (RX)theglobeandmail.com - April 6 at 4:43 PMBioSyent Inc. (CVE:RX) On An Uptrend: Could Fundamentals Be Driving The Stock?finance.yahoo.com - March 27 at 12:32 PMBioSyent Inc.: BioSyent Releases Financial Results for Fourth Quarter and Full Year 2022finanznachrichten.de - March 22 at 10:31 AMBioSyent Releases Financial Results for Fourth Quarter and Full Year 2022finance.yahoo.com - March 21 at 6:14 PMBioSyent Declares First Quarter 2023 Dividendyahoo.com - February 1 at 6:59 PMA Look At The Fair Value Of BioSyent Inc. (CVE:RX)nz.finance.yahoo.com - December 29 at 7:49 AMBioSyent Signs Exclusive Agreement for Oncology Supportive Care Productfinance.yahoo.com - December 14 at 7:30 PMShareholders in BioSyent (CVE:RX) are in the red if they invested five years agofinance.yahoo.com - December 4 at 6:31 PMBioSyent Inc.: BioSyent Releases Q3 and YTD 2022 Financial Resultsfinanznachrichten.de - November 17 at 7:35 AMBioSyent Releases Q3 and YTD 2022 Financial Resultsyahoo.com - November 16 at 9:34 PMAre BioSyent Inc.'s (CVE:RX) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?finance.yahoo.com - October 17 at 4:18 PM Get BioSyent News Delivered to You Automatically Sign up to receive the latest news and ratings for RX and its competitors with MarketBeat's FREE daily newsletter. Email Address At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… RX Media Mentions By Week RX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RX News Sentiment▼0.000.45▲Average Medical News Sentiment RX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RX Articles This Week▼00▲RX Articles Average Week Get BioSyent News Delivered to You Automatically Sign up to receive the latest news and ratings for RX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Charlotte's Web News HLS Therapeutics News Cardiol Therapeutics News MediPharm Labs News Cipher Pharmaceuticals News Organigram News Oncolytics Biotech News Medicenna Therapeutics News Theratechnologies News Spectral Medical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:RX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHow to camouflage a factory of 53,000 workersStansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSyent Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
